Septerna Stock Plummets to New Low After Ending Trial

WSJFeb 18 10:26 ET

US Stocks Mixed; NY State Business Activity Rises In February

BenzingaFeb 18 09:45 ET

Wells Fargo Downgrades Septerna(SEPN.US) to Hold Rating, Cuts Target Price to $14

Moomoo NewsFeb 18 09:34 ET · Ratings

Septerna Discontinues Phase 1 Trial of SEP-786 for Hypoparathyroidism; Shares Fall Pre-Bell

MT NewswiresFeb 18 08:44 ET

Septerna Shares Are Trading Lower After the Company Announced the Discontinuation of Its Phase 1 Trial of SEP-786 Due to Unanticipated Bilirubin Events.

BenzingaFeb 18 08:40 ET

Hold Rating for Septerna, Inc. Amid Lead Program Discontinuation and Pipeline Uncertainty

TipRanksFeb 18 08:35 ET · Ratings